Log In
Print
BCIQ
Print
Print this Print this
 

EGEN-001

  Manage Alerts
Collapse Summary General Information
Company Egen Inc.
DescriptionIL-12-expressing plasmid formulated with a lipopolymeric gene delivery system
Molecular Target Interleukin-12 (IL-12)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Non-viral vector

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today